PHARMACEUTICAL COMBINATIONS FOR TREATMENT AND OF DIABETES MELLITUS

A pharmaceutical combination comprises (a) at least one enzymatic nitric oxide (NO) donor; (b) optionally at least one anti-diabetic ingredient; (c) additionally optionally a carrier; (d) and/or other auxiliaries. ACTIVITY : Antidiabetic; Nephrotropic; Neuroprotective; Ophthalmological; Cardiant; Ce...

Full description

Saved in:
Bibliographic Details
Main Authors SZILVASSY ZOLTAN DR, FERNINANDY PETER DR, TOSAKI ARPAD DR, KOVACS PETER DR, HERNADI FERENC DR, NEMETH JOZSEF DR, PANKUCSI CSABA DR
Format Patent
LanguageEnglish
Published 02.05.2007
Online AccessGet full text

Cover

Abstract A pharmaceutical combination comprises (a) at least one enzymatic nitric oxide (NO) donor; (b) optionally at least one anti-diabetic ingredient; (c) additionally optionally a carrier; (d) and/or other auxiliaries. ACTIVITY : Antidiabetic; Nephrotropic; Neuroprotective; Ophthalmological; Cardiant; Cerebroprotective; Antiinflammatory. MECHANISM OF ACTION : Platelet aggregation inhibitor, inhibitor of Ca 2> +> entry into cardiac myaytes, and inhibitor of catecholamine release from cardiac adrenergic nerve terminal.
AbstractList A pharmaceutical combination comprises (a) at least one enzymatic nitric oxide (NO) donor; (b) optionally at least one anti-diabetic ingredient; (c) additionally optionally a carrier; (d) and/or other auxiliaries. ACTIVITY : Antidiabetic; Nephrotropic; Neuroprotective; Ophthalmological; Cardiant; Cerebroprotective; Antiinflammatory. MECHANISM OF ACTION : Platelet aggregation inhibitor, inhibitor of Ca 2> +> entry into cardiac myaytes, and inhibitor of catecholamine release from cardiac adrenergic nerve terminal.
Author KOVACS PETER DR
NEMETH JOZSEF DR
FERNINANDY PETER DR
PANKUCSI CSABA DR
SZILVASSY ZOLTAN DR
TOSAKI ARPAD DR
HERNADI FERENC DR
Author_xml – fullname: SZILVASSY ZOLTAN DR
– fullname: FERNINANDY PETER DR
– fullname: TOSAKI ARPAD DR
– fullname: KOVACS PETER DR
– fullname: HERNADI FERENC DR
– fullname: NEMETH JOZSEF DR
– fullname: PANKUCSI CSABA DR
BookMark eNqNyjsOwjAMANAMMPC7gzkAUihDZyd11Ej5VK07VxUyE0orlfuLhQMwveUd1a4sRQ7KdC32ES2N7C0GsDkan5B9TgO43AP3hBwpMWBqIDtoPBpiGiBSCJ7H4az2r_m9yeXnSV0dsW1vsi6TbOv8lCKfqR07XWt9r2qsHv-cLypXLUE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID HUP0700127A2
GroupedDBID EVB
ID FETCH-epo_espacenet_HUP0700127A23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:07:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HUP0700127A23
Notes Application Number: HUP0700127
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070502&DB=EPODOC&CC=HU&NR=P0700127A2
ParticipantIDs epo_espacenet_HUP0700127A2
PublicationCentury 2000
PublicationDate 20070502
PublicationDateYYYYMMDD 2007-05-02
PublicationDate_xml – month: 05
  year: 2007
  text: 20070502
  day: 02
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies KERI PHARMA KFT
RelatedCompanies_xml – name: KERI PHARMA KFT
Score 2.67168
Snippet A pharmaceutical combination comprises (a) at least one enzymatic nitric oxide (NO) donor; (b) optionally at least one anti-diabetic ingredient; (c)...
SourceID epo
SourceType Open Access Repository
Title PHARMACEUTICAL COMBINATIONS FOR TREATMENT AND OF DIABETES MELLITUS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070502&DB=EPODOC&locale=&CC=HU&NR=P0700127A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFA5jinrTqej8QQTprRib1OKhSJumdELXsqWy22jaDuahG67iv-9rtjkvegsJPJLA9773krwvCN1TAkF9-WybStHcZBZRpqKUmawkRcGAsXP981w8fIoy9jqxJx30vq2F0TqhX1ocERBVAN4b7a-Xu0OsQL-tXD2oOXQtXkLpBsY2O3aITSwj8F2RJkHCDc7dKDOGIzcljr5l9cBd70EY7bRoEG9-W5Wy_E0p4THaT8Fa3ZygTlX30CHf_rzWQwfx5sIbmhvsrU6Rn0beKPa4yGSrYYB5EvuDtZjtGEMuh-VIeLLV5sfeMMBJiIOB5wspxjgWkLLLbHyG7kIheWTCZKY_K59G2W7e9Bx160VdXSAMMGS2VVqPeU4YZQ4wTMFmZVXQCqIFNbtE_b_t9P8bvEJH68PLtmz7GnWbj8_qBli3Ubd6u74B-jZ_zA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYrOWwTpW7G2qcWHIr2ktLpe2FLZ22jaDvShG67i3_e025wv-hYSOCSB73znJDlfAG41BYP64lGXhdAymaqKkIWmUZkWSp5TZOys_XkujB78lD5P9EkH3je1MK1O6FcrjoiIyhHvdeuvF9tDLLd9W7m8E2_YNX_yuOlKm-zYUHRFlVzbZEnsxo7kOKafStHITBSjvWW10F3vYIhtNGhgr3ZTlbL4TSneAewmaK2qD6FTVn3oOZuf1_qwF64vvLG5xt7yCOzEt0ah5bCUNxoGxIlDO1iJ2Y4J5nKEj5jFG21-YkUuiT3iBpbNOBuTkGHKztPxMdx4jDu-jJOZ_qx86qfbeWsn0K3mVXkKBGFIdbVQ77NMoRo1kGFyOivKXCsxWhCzMxj8bWfw3-A19HweDqfDIHo5h_3VQWZTwn0B3frjs7xEBq7FVbt13yRkgr8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMBINATIONS+FOR+TREATMENT+AND+OF+DIABETES+MELLITUS&rft.inventor=SZILVASSY+ZOLTAN+DR&rft.inventor=FERNINANDY+PETER+DR&rft.inventor=TOSAKI+ARPAD+DR&rft.inventor=KOVACS+PETER+DR&rft.inventor=HERNADI+FERENC+DR&rft.inventor=NEMETH+JOZSEF+DR&rft.inventor=PANKUCSI+CSABA+DR&rft.date=2007-05-02&rft.externalDBID=A2&rft.externalDocID=HUP0700127A2